Increased kidney growth in formula-fed versus breast-fed healthy infants

Ida M Schmidt1, Ida N Damgaard, Kirsten A Boisen

  • 1University Department of Growth and Reproduction, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. rh03096@rh.dk

Insights

Formula feeding in infants may temporarily increase kidney size and serum urea nitrogen, particularly in boys. These effects were not observed at 18 months, suggesting temporary renal changes from early protein intake.

Area of Science:

  • Pediatric Nephrology
  • Infant Nutrition
  • Developmental Biology

Background:

  • High protein intake is known to increase kidney size and glomerular filtration rate in adults and young rats.
  • The impact of increased protein intake from formula feeding on kidney development in young infants remains unclear compared to breast-fed infants.

Purpose of the Study:

  • To investigate the effect of formula versus breast feeding on kidney growth in healthy infants.
  • To assess immediate renal function markers in relation to feeding type.

Main Methods:

  • A cohort of 631 healthy children was studied from birth to 18 months.
  • Kidney size was measured using ultrasonography at birth, 3, and 18 months.
  • Serum urea nitrogen, creatinine, and creatinine clearance were measured at 3 months, correlating with feeding category (breast-fed, partially breast-fed, formula-fed).

Main Results:

  • Partially or fully formula-fed infants showed significantly increased kidney growth and serum urea nitrogen at 3 months.
  • These renal effects were more pronounced in boys than in girls.
  • The observed changes in relative kidney size were temporary, resolving by 18 months when all infants were on a mixed diet.

Conclusions:

  • Formula feeding is associated with immediate, temporary increases in infant kidney size and serum urea nitrogen.
  • These findings highlight the need to consider the renal effects of infant formula for feeding recommendations.
  • Long-term consequences of early high protein intake on later kidney function require further investigation.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...